Introduction
============

Air pollution has worsened in recent years, particularly anthropogenic sources due to the development of heavy industry in recent years. Particulate matter 2.5 (PM~2.5~), an index of air pollution, is defined as particulate matter with an aerodynamic diameter of less than 2.5 μm and can adversely affect the respiratory and circulatory systems of humans [@B1], [@B2]. Approximately 96% of PM~2.5~ were retained in the lungs given its size effect [@B3]. In addition, PM~2.5~ contains different components, such as polycyclic aromatic hydrocarbons, oxygenated volatile organic compounds and heavy metals, which exert toxic effects [@B4], [@B5].

The relationships between PM~2.5~ and inflammation have been mentioned in many pulmonary diseases, such as acute lung injury (ALI), asthma and chronic obstructive pulmonary disease (COPD) [@B6]-[@B8]. PM~2.5~-induced inflammation is associated with the release of numerous cytokines and chemokines, such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) and tumor growth factor beta 1 (TGF-β1). These cytokines activate the mitogen-activated protein kinase (MAPK) and Janus-activated kinase (JAKs) pathways [@B9]-[@B11]. Furthermore, matrix metalloproteinases (MMPs) are important factors in lung diseases and are regulated via the pathways of *signal transducer and activator of transcription 3* (STAT3) and MAPK signaling transducer [@B12], [@B13]. Therefore, the fundamental mechanism of PM~2.5~-induced ALI must be understood for the effective prevention of PM~2.5~-related pulmonary diseases.

Renin-angiotensin system (RAS) is an important endocrine system that regulates cardiovascular physiology and participates in pulmonary injury by activating inflammatory factors in the lung [@B14], [@B15]. The angiotensin-converting enzyme (ACE)/angiotensin II (Ang II)/Ang II type I receptor (AT1R) (ACE/Ang II/AT1R) axis and angiotensin-converting enzyme II (ACE2)/angiotensin 1-7 (Ang-(1-7))/Mas receptor (ACE2/Ang-(1-7)/Mas) axis are two pathways in RAS with opposing effects [@B16]. These two pathways counter-regulate the expression of pro-inflammatory factors. Increased ACE levels cause the activation of AT1R by Ang II, consequently inducing the expression of the inflammatory cytokines IL-6, TNF-α and TGF-β1 [@B17]. ACE2 counter-regulates the effects produced by Ang II by converting Ang II to Ang-(1-7), activates Mas to repress the signaling pathways of STAT3 and extracellular signal-regulated kinases (ERK) [@B18], and acts as an anti-inflammatory factor [@B19].

As mentioned above, PM~2.5~ is associated with various respiratory and cardiovascular diseases. Inflammation is one of its mechanisms. Interestingly, RAS is strongly related with the cardiopulmonary system and inflammation. Therefore, we hypothesized that PM~2.5~-induced ALI is regulated by RAS, and ACE2/Ang-(1-7)/Mas axis has a crucial role in the pathogenesis of lung injury. To test this hypothesis, we exposed C57BL/6 and ACE2 knockout (ACE2 KO) mice to PM~2.5~ collected from urban traffic. PM~2.5~ was administered to the mice through intratracheal instillation for 3 consecutive days. The mice were then sacrificed at 2 and 5 days after PM~2.5~ instillation. We then measured physiological parameters, expression levels and activities of ACE, ACE2, and MMPs in lung tissue. Furthermore, we detected the phosphorylation of ERK1/2 to p-ERK1/2 and of STAT3 to p-STAT3 to explore the potential mechanisms and the role of ACE2 in PM~2.5~-induced ALI~.~

Methods and materials
=====================

Source and analysis of PM~2.5~
------------------------------

Urban traffic is the major source of PM~2.5~ [@B20], [@B21]. We collected PM~2.5~ from traffic by continuous pumping air in accordance with the protocol of previous study with slight modifications [@B22], [@B23]. Particulates with diameters of 2 μm that attached to PTFE paper (TaiwanGrace International Co., Taichung, Taiwan) were carefully scraped to another piece of filter paper (Toyo Roshi Kaisha, Tokyo, Japan). Then, water was added to wash out particulates by suction filtration. The liquid was then collected and sonicated for 5 minutes, and this step was repeated thrice. The particulates were freeze-dried until excess water was completely removed. The particulates were sterilized and dissolved in DMSO (Sigma-Aldrich, Louis, MO, USA) to 10 mg/mL as stock for later use.

The collected PM~2.5~ were diluted to 10 μg/mL in acetone (Sigma-Aldrich) and dropped onto copper mesh for analysis through transmission electron microscopy (TEM) (Ted Pella, Redding, CA, USA). The TEM grids were incubated in an oven for 5 min. Finally, the configuration and elemental composition of PM~2.5~ were characterized using TECNAI 20 instrument (Philips, Netherlands) and a scanning electron microscope (Hitachi SU8010; Hitachi High-Technologies Co., Tokyo, Japan).

Animal treatment with PM~2.5~
-----------------------------

Six-week-old wild type (WT, C57BL/6, male) and ACE2 gene knockout (ACE2 KO, male) mice were respectively divided to the sham, 2 days and 5 days postinstillation group (n = 7 for each group; a total of 21 mice used) in this study. The WT mice were obtained from National Laboratory Animal Center (NLAC), Taiwan. The first ACE2 KO (B6, 129S5-Ace2tm1 Lex/Mmcd) mice were purchased from Mutant Mouse Regional Resource Centers (MMRRC) and breed in NLAC [@B15]. All of the animal experiments conformed to the "Guide for the Care and Use of Laboratory Animals published by National Institutes of Health" (NIH Publication No. 85-23, revised 1996) and was approved by the Animal Welfare Committee of National Chiao Tung University (NCTU-IACUC-104026).

The mice were treated once daily with PM~2.5~ in 100 μL saline solution (6.25 mg/kg/day) via intratracheal instillation for 3 consecutive days and sacrificed at 2 and 5 days postinstillation. The sham group was treated with saline by intratracheal instillation. The body weight and resting respiratory rate (RRR) of the mice were measured daily. The RRR (BPM, breaths per minute) of the mice was measured in accordance with the protocol of a previous study with some modifications [@B24]. The RRR of mice after 15 min of exercise was detected daily before saline or PM~2.5~ treatment by using whole-body unrestrained chambers (Emka, Middletown, PA, USA). RRR data were analyzed by BIOPAC Student Lab Systems software (Biopac System, Goleta, CA, USA) [@B24].

Enzyme-linked immunosorbent assay (ELISA) and Western blot
----------------------------------------------------------

Pulmonary TNF-α, TGF-β1 and IL-6 were detected by sandwich ELISA (Abcam, Cambridge, MA, USA). Proteins were incubated in 96-well ELISA plates with primary antibodies. After the addition of biotinylated antibodies, the plates were washed and reacted with HRP-conjugated streptavidin. Tetramethylbenzidine (TMB) one-step substrate tablets for the detection of TNF-α, TGF-β1 or IL-6, and the results were measured at 450 nm using a micro-plate reader (Thermo Scientific, Waltham, MA, USA).

Lung homogenates with an equivalent protein content of 25 μg protein were electrophoresed on 12% SDS-PAGE gels and then transferred to polyvinylidene fluoride membranes (Immobilon-PTM; Millipore, Bedford, MA, USA). The primary ACE, ACE2, phosphor-STAT3, phosphor-ERK1/2, STAT3, ERK1/2 and β-actin antibodies were obtained from Genetex (Irvine, CA, USA) or Cell Signaling Technology (Beverly, MA, USA). Immunoreactivity was detected through enhanced chemiluminescence (Immobilon Western Chemiluminescent HRP Substrate; Millipore, Billerica, MA, USA). PAGE membranes were exposed in Lumi-Film Chemiluminescent Detection Film (Roche, Indianapolis, IN, USA). Band density was measured with Scion Image software (Scion, Frederick, MD, USA). The levels of ACE and ACE2 were normalized to that of β-actin, and those of p-ERK1/2 and p-STAT3 were normalized to that of total ERK1/2 and STAT3, respectively.

Gelatin zymography assay
------------------------

Lung MMP-2 and MMP-9 activities were detected through gelatin zymography with gelatin-containing gels in accordance with our previously reported protocol [@B26]. Lung homogenates were mixed with 6× zymography sample buffer (0.375 M Tris-HCl, pH 6.8, 20% (v/v) glycerol, 12% (w/v) SDS, and 0.015% bromophenol blue), incubated for 10 min at 37℃, and loaded onto 10% acrylamide gels with 0.1% (w/v) gelatin (Sigma-Aldrich) for SDS-PAGE. After electrophoresis, the gel was washed twice with zymography renaturing buffer (2.5% Triton X-100) for 30 min and incubated in developing buffer (50 mM Tris-HCl, pH 7.4, 200 mM NaCl, 5 mM CaCl~2~, and 0.02% Brij35) for 20 h at 37°C. The gels were then stained with Coomassie blue for 30 min and further distained with destaining buffer (50% methanol, 10% acetic acid, and 40% ddH~2~O). MMP-2 and MMP-9 activities were determined on the basis of clear or unstained areas, which are indicative of enzyme activity on the gelatin substrate. The unstained areas were quantified by using Scion Image software (Scion). Each gel contained MMP-2 or MMP-9 positive controls (Chemicon, Temecula, CA, USA) for the standardization of intensity value to sample intensity and expressed in arbitrary units [@B27].

*In situ* zymography
--------------------

Tissue treatment and *in situ* zymography were performed in accordance with our previous report [@B15]. Lung tissues were collected and embedded in O.C.T. (Thermo, Waltham, MA, USA), immediately frozen, and stored at -80℃. Frozen tissue was cut into 7-10 μm thick sections on a slide. Then, 20 μL substrate gel solution was placed on the surface of the tissue sample. Another slide was then placed on top of the first slide to form a sandwich. The slides were placed in a box that contained Tris buffer (pH 7.4) at 37℃ and protected from light for 20 h. Substrate that was broken down by gelatinase emitted green fluorescent signal. Fluorescence images were taken using a Leica SP5X confocal laser-scanning microscope (Leica, Wetzlar, Hesse, Germany).

Histological determination
--------------------------

Lung tissues were collected from C57BL/6 and ACE2 KO mice, soaked in 10% formaldehyde overnight, embedded in paraffin, and cut into 4 μm-thick sections on acid-pretreated slides for Hematoxylin/ Eosin (H&E) and immunohistochemical (IHC) staining. The tissue samples were incubated with primary IHC antibody against TGF-β1 (1:2000; Genetex) at 4°C overnight and then with HRP-labeled Goat Anti-Mouse IgG (H + L) as a secondary antibody (1:100 dilution) at 37°C for 30 min. The stained pathological sections were photographed by a digital camera mounted on a microscope. A computerized microscope equipped with a high-resolution video camera (BX 51; Olympus, Tokyo, Japan) was used for morphometric analysis.

Statistical analysis
--------------------

All values were expressed as the mean ± standard deviation. Student\'s *t*-test was performed for comparisons between two groups. One-way analysis of variance (ANOVA) test was performed to evaluate differences among multiple groups. A value of *p* \< 0.05 was considered statistically significant.

Results
=======

PM~2.5~ characterization
------------------------

Configurations of the PM~2.5~ collected in the present study were shown in **Fig. [1](#F1){ref-type="fig"}**. The PM~2.5~ comprised numerous small particulates with diameters of 500 nm **(Fig. [1](#F1){ref-type="fig"}A)**. These small particulates may be aggregated or dispersed **(Fig. [1](#F1){ref-type="fig"}B** and**1C)** and form large particles with diameters of approximate 2.5 μm (i.e., PM~2.5~) **(Fig. [1](#F1){ref-type="fig"}D)**. The elemental composition of the particulates was characterized. **Figs. [1](#F1){ref-type="fig"}E** and **1F** show the silicon crystal and sulfur components of the collected PM~2.5~, respectively.

PM~2.5~-induced ALI associated with inflammation
------------------------------------------------

WT and ACE2 KO mice were treated with PM~2.5~ via intratracheal instillation once a day for 3 days and sacrificed at 2 and 5 days postinstillation. Body weight and RRR of the animals were monitored daily until sacrifice. The body weight of WT and ACE2 KO mice were markedly decreased throughout the entire PM~2.5~ treatment period and slightly recovered to almost their initial body weight at 5 days postinstillation (**Fig. [2](#F2){ref-type="fig"}**). However, the WT and ACE2 KO mice in the sham (saline treatment) control steadily gained body weight during the experimental period. RRR in the WT and ACE2 KO mice significantly increased during PM~2.5~ instillation period and remained at a high level at 5 days postinstillation (**Fig. [3](#F3){ref-type="fig"}**). Compared with those of the mice of PM~2.5~ treatment group, RRR of the WT and ACE2 KO mice in the sham group remained below 330 BPM throughout the experimental period.

Inflammatory cytokine levels were determined to confirm that whether PM~2.5~ instillation could induce pulmonary inflammation in mice. At 2 days postinstillation, IL-6, TGF-β1 and TNF-α levels in the lungs significantly increased by 2.1-, 1.5- and 1.9-fold in WT mice, and 2.3-, 1.5- and 2.0-fold in ACE2 KO mice, respectively (**Fig. [4](#F4){ref-type="fig"}**). At 5 days postinstillation, the levels of IL-6 and TNF-α in the lungs of WT mice returned to almost their basal levels, whereas that of TGF-β1 still increased by 1.3-fold. IL-6, TGF-β1 and TNF-α levels in the lungs of ACE2 KO mice increased by 1.7-, 1.5-, 1.6-fold at 5 days postinstillation, respectively. In particular, IL-6 and TGF-β1 levels in ACE2 KO mice were significantly higher than those in WT mice (**Fig. [4](#F4){ref-type="fig"}**). The expression and distribution of TGF-β1 in the lungs were also detected by IHC staining (**Fig. [5](#F5){ref-type="fig"}**). TGF-β1 level in the lung tissues, especially in the bronchus, significantly increased at 2 and 5 days postinstillation.

Lung sections from the WT and ACE2 KO mice were subjected to H&E staining, which revealed extensive white blood cells infiltration around the bronchus and airway epithelial thickening in WT and ACE2 KO mice at 2 days postinstillation (**Fig. [6](#F6){ref-type="fig"}**). The extent of infiltration and airway epithelial thickening in the WT and ACE2 KO mice decreased at 5 days postinstillation, but still more severe than that of sham group. Alveolar damage and fusion were also found in the mice at 5 days postinstillation (**Fig. [7](#F7){ref-type="fig"}**). Moreover, infiltration and airway epithelial thickening were more extensive in the ACE2 KO mice than those in WT mice after PM~2.5~ treatment.

Effects of PM~2.5~ on ACE and ACE2 expression
---------------------------------------------

To identify the RAS mediators associated with PM~2.5~-induced ALI, the protein expression of ACE and ACE2 in the pathogenesis of lung injury induced by PM~2.5~ were investigated.

**Fig. [8](#F8){ref-type="fig"}A** shows that ACE expression in the lungs of WT and ACE2 KO mice was significantly increased by 1.3- and 1.8-fold, respectively, compared with those in the lungs of sham group mice at 2 days postinstillation. Notably, ACE expression in the lungs of WT and ACE2 KO mice significantly decreased to 0.4- and 0.8-fold which was a level lower than that in the sham group at 5 days postinstillation. The ACE expression level in WT mice was only one half compared with that in ACE2 KO mice. ACE2 expression in the lungs of WT mice significantly increased at both 2 and 5 days postinstillation, and markedly increased ACE2 expression level at 2 days postinstillation reduced at 5 days postinstillation (**Fig. [8](#F8){ref-type="fig"}B**).

Effects of PM~2.5~ on lung gelatinase activity
----------------------------------------------

Gelatinase containing MMP-2 and MMP-9 was subjected to *in situ* zymography assay to compare the gelatinase localization and activity in the lungs of WT and ACE2 KO mice.

Gelatinase activity mainly localized near the bronchus (**Fig. [9](#F9){ref-type="fig"}**). Gelatinase activity significantly increased in the lung of WT and ACE2 KO mice at 2 days postinstillation, as shown by thickening area in the mouse bronchus (**Fig. [9](#F9){ref-type="fig"}B**). At 5 days postinstillation, pulmonary gelatinase activity of the WT and ACE2 KO mice decreased, but remained higher than that in samples from the sham group.

To confirm that ACE2 deficiency affects lung gelatinase activity, the activity of MMP-2 and MMP-9 determined by gelatin zymography assay was performed. MMP-2 activity significantly increased in the lungs of WT mice, but only slightly increased in the lungs of ACE2 KO mice after PM~2.5~ treatment (**Fig. [10](#F10){ref-type="fig"}A**). Furthermore, MMP-9 activity in the lung increased in both WT and ACE2 KO mice at 2 days postinstillation. MMP-9 activity was also increased at 5 days postinstillation in the lungs of ACE2 KO mice, but not in those of WT mice (**Fig. [10](#F10){ref-type="fig"}B**).

ACE2 knockdown increases p-STAT3 and p-ERK1/2 in PM~2.5~-induced ALI
--------------------------------------------------------------------

The above results show that the levels of inflammatory cytokines and inflammation in pulmonary system were significantly induced after the mice treated with PM~2.5~. IL-6, TGF-β1 and TNF-α participate in inflammatory responses by activating the MAPK and JAK-STAT3 signaling pathways. To further explore whether the ACE2 knockdown would also influence the mediators of MAPK and JAK-STAT3 signaling pathways in PM~2.5~-induced ALI, we detected ERK1/2 and STAT-3 phosphorylation in the lung tissues by Western blotting.

The results show that in the lungs of WT mice, pulmonary p-ERK1/2 and p-STAT3 levels in the lungs of WT mice significantly increased by 2.2- and 1.7-fold at 2 days postinstillation, respectively, but recovered to normal levels at 5 days postinstillation. Similarly, the pulmonary p-ERK1/2 and p-STAT3 levels in ACE2 KO mice significantly increased by 2.3- and 1.5-fold at 2 days postinstillation. However, increased p-ERK1/2 and p-STAT3 levels in the lungs of ACE2 KO mice remained at a relative higher level at 5 days postinstillation compared those in the WT mice (**Fig. [11](#F11){ref-type="fig"}**). Additionally, the recovery effect on the pulmonary p-STAT3 in ACE2 KO mice was not observed.

Discussion
==========

The results of this study show that PM~2.5~ collected from urban traffic can induce lung injury through mechanisms that are similar, but a little different from those reported in another study due to the elements composition of PM~2.5~ [@B28]. Carbon and oxygen are the major constituents of PM~2.5~ in our collection and account for 47.1% and 40.8%, respectively, of the total weight of the particulates. The minor constituent elements silicon, sulfate and copper contributed 9.1%, 0.5% and 2.6%, to the total weight of the particulates, respectively. The heavy metal and transition metal contents of PM~2.5~ would cause injury through their size effect and toxicity [@B4], [@B5]. However, given the lack of harmful elements, such as arsenic, cadmium and mercury in the PM~2.5~ collected in this study, the size effect might be the major mechanism that causes injuries in mice.

In this study, ACE2 KO mice were utilized to investigate the role of ACE2 in PM~2.5~-induced ALI. In previous studies, PM~2.5~ dosage used to induce ALI was usually under 100 µg [@B29], [@B30]. We used higher dosage in this study to induce ALI as to close to reality. The PM~2.5~ concentration in developed countries is usually low, but much higher in developing countries such as China. In the winter, the level of PM~2.5~ can exceed more than 200 µg/m^3^ and maintain for several days [@B31], [@B32]. In our study, PM~2.5~ was mainly administered to experimental animals through intratracheal instillation [@B29], [@B30] or through aerosol inhalation in an exposure chamber that contains PM~2.5~ [@B33], [@B34] for consecutive 3 days, to imitate the reality of how PM~2.5~ invades our body. Furthermore, we selected intratracheal administration given its accurate and rapid delivery of PM~2.5~ to the tracheae. The effect after administration of PM~2.5~ through aerosol inhalation is affected by many factors including mouse physiological stability and RRR, and may not have stable effects [@B33]. Compared with aerosol inhalation, intratracheal administration can decrease dose loss and better represent the relationship between dosage and pathological changes [@B33]. However, one of limitations in the use of intratracheal instillation in animal models is that particulates may be unevenly distributed and accumulate in some sections of the lungs after PM~2.5~ instillation [@B34], [@B35]. Another limitation is that intractracheally instilled PM~2.5~ may not reproduce the pathological reactions induced by inhaled PM~2.5~. Despite these limitations, intratracheal instillation still reveals the adverse effects caused by PM~2.5~.

Recent studies indicated that PM~2.5~ can induce inflammatory response and can recruit numerous inflammatory cytokines, such as TGF-β1, TNF-α and IL-6 [@B9]-[@B11]. Several pulmonary diseases, e.g., asthma, ALI, COPD and acute respiratory distress syndrome (ARDS), are associated with abnormal TGF-β1, TNF-α and IL-6 expression [@B38]-[@B40]. Our results accordingly show that TGF-β1, TNF-α and IL-6 levels in the lungs of WT and ACE2 KO mice significantly increased at 2 days postinstillation**(Fig. [4](#F4){ref-type="fig"})**. Moreover, the lung sections also showed serious infiltration and injury**(Fig. [5](#F5){ref-type="fig"} and Fig. [6](#F6){ref-type="fig"})**. The experimental results indicated that severe inflammation was induced at 2 days postinstillation. However, inflammation decreased at 5 days postinstillation **(Fig. [4](#F4){ref-type="fig"})**. The impact of PM~2.5~ may be very strong at the beginning of exposure, especially as the dosage use in this study was larger than that used in other studies [@B41], [@B42]. Few days after PM~2.5~ exposure, the function of self-repair in the body may attenuate the injury [@B43]. TGF-β1 and IL-6 levels in the lungs of ACE2 KO mice were higher than in those of WT mice at 5 days postinstillation. Pathogenic lesions and inflammation were also more severe in the lungs of ACE2 KO mice than those in WT mice. Lung injury in ACE2 KO mice was more severe than that in WT mice at 5 days postinstillation. The results imply that a massive dose of PM~2.5~ exposure could induce severe pulmonary inflammation and tissue injury, and the injury could recover when mice are no longer exposed to PM~2.5~. Moreover, the existence of ACE2 in the lung might be crucial in the repair of PM~2.5~-induced ALI given that ACE2 KO mice exhibited more severe inflammation than WT mice.

Furthermore, ACE and ACE2 levels changed after PM~2.5~ treatment. The results show that ACE expression in the lung increased at 2 days postinstillation with a trend that opposed that at 5 days postinstillation (**Fig. [8](#F8){ref-type="fig"}A**). In the previous study, ACE expression in lung injury is controversial as it had been reported to exhibit either increasing or decreasing trend. For instance, hypertensive rats instilled with PM~2.5~ showed that ACE levels increased in the heart but decreased in the lung at 1 and 3 days postinstillation [@B44]. Similarly, when Sprague-Dawley (SD) rats were acutely exposed to particulates through aerosol inhalation for 3 days, ACE levels in the lung decreased. However, when the SD rats were subchronically (8 weeks) exposed to particulates using a particulate concentrator, lung ACE protein level and mRNA levels increased [@B45], [@B46]. We speculated that ACE increased in the lung because the lung is a major organ of ACE production and the initiation of PM~2.5~ treatment induced ACE expression [@B47]. However, ACE expression in the lung gradually normalized after instillation, and ACE in the lung might enter the circulatory system, thus causing ACE levels in the lung to decrease. Additionally, ACE expression in the lungs of ACE2 KO mice was higher than that in WT mice at 2 and 5 days postinstillation (**Fig. [8](#F8){ref-type="fig"}A**). A possible reason for this result is that ACE2 KO mice got more injuries and recovered slower induced by PM2.5 than WT mice after PM~2.5~ treatment.

Compared with ACE, the importance of ACE2 in PM~2.5~-induced ALI is seldom discussed. Imai et al. [@B48] reported that ACE2 has protective functions in murine lungs and can attenuate the acute injury induced by ARDS and SARS. In addition, ACE2 acts as a central role in lung endothelial function and pathophysiology [@B19], [@B49]. For example, lung injury induced by cigarette smoke exposure, and pulmonary fibrosis induced by bleomycin are associated with ACE2 activity [@B15], [@B50]. In our study, ACE2 expression in the lung increased at 2 and 5 days postinstillation (**Fig. [8](#F8){ref-type="fig"}B**), and PM~2.5~-induced ALI in ACE2 KO mice was more severe than that in WT mice. We speculated that the activation of ACE2/Ang-(1-7)/Mas receptor axis is absent in ACE2 KO mice. Thus, ACE2 KO mice sustained severe injuries and inflammation from PM~2.5~ exposure. On the basis of these findings, we hypothesized that ACE2 has a protective role against lung injury induced by PM~2.5~.

The members of MMP family, particularly gelatinase MMP-2 and MMP-9, are highly related with pulmonary inflammation and lung disease, such as asthma, ALI, and pulmonary fibrosis [@B51], [@B52]. Although MMP-9 and MMP-2 are the target enzymes of tissue remodeling, they have different roles in lung injury [@B51]. MMP-2 is synthesized by structural cells, including fibroblasts and endothelial and epithelial cells; MMP-2 is associated with impaired tissue remodeling, thus leading to pathological collagen deposition and pulmonary fibrosis [@B53], [@B54]. By contrast, MMP-9 is mainly secreted by the neutrophils, eosinophils, mast cells, alveolar macrophages, and is associated with acute inflammation [@B55]. Our results show that MMP-2 significantly increased in the lungs of WT and ACE2 KO mice at 2 and 5 days postinstillation (**Fig. [10](#F10){ref-type="fig"}A**). This result indicates that lung was undergoing repair with time after PM~2.5~ treatment. These results, combined with that for inflammation, confirm that PM~2.5~ -induced ALI can be repaired. Furthermore, MMP-2 activity in WT mice is higher than that in ACE2 KO mice at 2 and 5 days postinstillation, which indicated that WT mice exhibited more extensive tissue remodeling and might have faster recovery than ACE2 KO mice. On the other hand, MMP-9 increased in the lungs of WT and ACE2 KO mice at 2 days postinstillation but only remained at higher level in those of ACE2 KO mice at 5 days postinstillation (**Fig. [10](#F10){ref-type="fig"}B**). Under severe inflammation at 2 days postinstillation, MMP-9 activity elevated more significantly in the lungs of ACE2 KO mice than in WT mice. At 5 days postinstillation, inflammation in the lungs of WT mice decreased as MMP-9 normalized, but activation of inflammatory response persisted in ACE2 KO mice as MMP-9 activity remained in slightly increased level (as compared with the sham group). The lack of ACE2 would increase MMP-9 activity in lungs through inflammation, thus affecting recovery after PM~2.5~ instillation. Therefore, ACE2 likely plays an important role in the repair of PM~2.5~-induced injury.

The results of our study show that PM~2.5~ induces severe inflammatory response and unbalances the RAS system. The RAS system is involved in inflammatory response in several lung diseases [@B14], [@B15]. Inflammatory cytokines, such as TNF-α, IL-6 and TGF-β1, are associated with MAPK pathways [@B9]-[@B11]. ACE2 is associated with the regulation of the ERK-p38 and JAK-STAT signaling pathways [@B15], [@B56]. Moreover, MMPs participate in tissue repair through the mediation of transcription factors, e.g., STAT-3, that might indirectly activate MAPK signal pathways [@B57], [@B58]. Therefore, the changes in the phosphorylation of ERK1/2 and STAT3 in the lung after PM~2.5~ treatment were investigated in this study. The result shows that PM~2.5~-induced ALI is associated with the MAPK pathway. p-ERK1/2 and p-STAT3 levels in the lungs significantly increased at 2 days postinstillation (**Fig. [11](#F11){ref-type="fig"}**). The results demonstrate that PM~2.5~ causes lung injury via ERK1/2 and STAT3 signaling pathways and are consistent with the conclusions of previous reports that p38, ERK1/2 and JNK phosphorylation regulate key inflammatory, proteolytic and apoptotic responses in the lungs [@B59], [@B60]. Interestingly, p-ERK1/2 and p-STAT3 levels decreased to normal levels in the lungs of WT mice but remained at significantly increased levels in ACE2 KO mice at 5 days postinstillation (**Fig. [11](#F11){ref-type="fig"}**). The result suggests that inflammation and RAS were alleviated and PM~2.5~-induced ALI was also attenuated in WT mice. However, the ACE2 KO mice sustained severe injuries and exhibited slow recovery, inflammatory responses and RAS change, which caused the ERK1/2 and STAT3 signaling pathway to remain to be activated at 5 days postinstillation. These observations are consistent with the results mentioned above: the absence of ACE2 would affect and regulate the protective function that retards PM~2.5~-induced ALI.

Conclusions
===========

The present study is the first to use a mouse model of PM~2.5~-induced ALI to investigate the effects of ACE2 deficiency. ACE2 deficiency would attenuate injury repair, inflammatory response and tissue remodeling in response to PM~2.5~ instillation. Therefore, ACE2 may have protected the respiratory system from PM~2.5~-induced injuries. Further studies, however, are necessary to validate this conclusion. Moreover, circulating or lung Ang II and Ang-(1-7) and the actions of both peptides on PM~2.5~-induced ALI remain to be further explored.
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![**TEM images of PM~2.5~ configuration.** Configurations of the particulates collected from traffic were shown under transmission electron microscopy. The small particles which were 500 nm in size **(A)** distributed in many types **(B) (C)** and formed PM~2.5~ **(D)**. Few particles showed other different composition such as silicon **(E)** or sulfur**(F)**.](ijbsv14p0253g001){#F1}

![**Changes in the body weight of WT and ACE2 KO mice.** WT (C57BL/6, n = 7 for each group) and ACE2 KO mice (n = 7 for each group) treated with PM~2.5~ or saline by intratracheal administration for consecutive 3 days and sacrificed at 2 and 5 days postinstillation. Body weight of WT **(A)** and ACE2 KO mice **(B)** were detected every day until sacrifice. All values are expressed as the mean from each group; \* *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001 compared with the body weight in the same day.](ijbsv14p0253g002){#F2}

![**Changes in the RRR of WT and ACE2 KO mice.** The RRR of WT and ACE2 KO mice were measured every day until sacrifice. The RRR increased after PM~2.5~ administration, and RRR of ACE2 KO mice was higher than RRR of WT mice at 6 days and 7 days. All values are expressed as the mean ± SD from each group; \* *p* \< 0.05 compared with the initial (i.e., 0 day) RRR in the same group; † *p* \< 0.05 compared with RRR of ACE2 KO mice to RRR of WT mice in the same day.](ijbsv14p0253g003){#F3}

![**Cytokines expression in the lungs of ACE2 KO mice after PM~2.5~ treatment.** WT mice and ACE2 KO mice treated with PM~2.5~ for consecutive 3 days and sacrificed at 2 and 5 days postinstillation. The expressions of IL-6 **(A)**, TGF-β1 **(B)** and TNF-α **(C)** in isolated lung tissue were determined by ELISA. All values are expressed as the mean ± SD from each group; \* *p* \< 0.05, \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001 compared with the Sham value in the same group; † *p* \< 0.05 and †† *p* \< 0.01 compared with the value of 5 days to 2 days postinstillation in same group; \# *p* \< 0.05 compared with the value of ACE2 KO mice to WT mice in the same day.](ijbsv14p0253g004){#F4}

![**Immunohistochemistry staining for TGF-β1 expression in bronchial tissue from ACE2 KO mice after PM~2.5~ treatment.** The TGF-β1 (dark brown) of WT **(A)** and ACE2 KO mice **(B)** distributed only on a thin layer in bronchus and around blood cells in the sham group. Compared to sham group, the pulmonary TGF-β1 accumulated in bronchus at 2 days postinstillation, and numerous white blood cells (blue) infiltrated. However, the pulmonary TGF-β1 reduced but still obviously accumulated in bronchus at 5 days postinstillation. Images were captured at medium magnification (Scale = 50 μm).](ijbsv14p0253g005){#F5}

![**Pathology of bronchial tissue from WT and ACE2 KO mice after PM~2.5~ treatment.** The lung bronchus sections of WT **(A)** and ACE2 KO mice **(B)** after PM~2.5~ instillation were stained with haematoxylin-eosin (H&E). Relative to initiation of sham mice, the white blood cells markedly infiltrated after PM~2.5~ treatment, especially at 2 days postinstillation. Besides, the bronchus wall was significantly thickened at 2 days postinstillation but the airway epithelial thickening reduced at 5 days postinstillation. Images were captured at medium magnification (Scale = 50 μm).](ijbsv14p0253g006){#F6}

![**Pathology of alveolar tissue from WT and ACE2 KO mice after PM~2.5~ treatment.** The lung alveolar sections of WT **(A)** and ACE2 KO mice **(B)** after PM~2.5~ treatment were stained with haematoxylin-eosin (H&E). Relative to initiation of sham mice, the white blood cells markedly infiltrated and airway epithelial was thickening after PM~2.5~ treatment. Besides, the ruptured alveoli were revealed at 5 days postinstillation. Images were captured at medium magnification (Scale = 100 μm).](ijbsv14p0253g007){#F7}

![**Change in ACE and ACE2 expressions in the lungs of mice after PM~2.5~ treatment.** The pulmonary ACE and ACE2 expression were determined by western blot. β-actin was used as the internal control for ACE and ACE2. The value of ACE and ACE2 expression in non-PM~2.5~ treatment was calculated in 100% as the sham value. The relative changes of pulmonary ACE expression in WT and ACE2 KO mice at 2 and 5 days postinstillation **(A)**. The relative changes of pulmonary ACE2 expression in ACE2 KO mice at 2 and 5 days postinstillation **(B)**. All values are expressed as the mean ± SD from each group; \* *p* \< 0.05 and \*\* *p* \< 0.01 compared with the Sham value in the same group; † *p* \< 0.05, †† *p* \< 0.01 and ††† *p* \< 0.001 compared with 5 days to 2 days postinstillation in same group; \# *p* \< 0.05 compared with the ACE2 KO mice to WT mice in the same day.](ijbsv14p0253g008){#F8}

![**Change and distribution of gelatinase activity in the bronchus of WT and ACE2 KO mice after PM~2.5~ treatment.** The location and gelatinase activity in the lungs of WT **(A)** and ACE2 KO mice **(B)** were detected by *in situ* zymography. The gelatin substrate was digested by MMPs and was shown in green, the nuclear signal was stained and was shown in red. Gelatinase activity around the bronchus was significantly increased after PM~2.5~ treatment. Images were captured at medium magnification (Scale = 50 μm).](ijbsv14p0253g009){#F9}

![**Relative MMP-2 and MMP-9 activities in the lungs of mice after PM~2.5~ treatment.** WT and ACE2 KO mice treated with PM~2.5~ or saline by intratracheal administration for consecutive 3 days and sacrificed at 2 and 5 days postinstillation. The pulmonary MMP-2 and MMP-9 activity was determined by gelatin zymography. The value of MMP-2 and MMP-9 activity in non-PM~2.5~ treatment was calculated in 100% as the sham value. The pulmonary MMP-2 activity**(A)** increased in the lungs of WT and ACE2 KO mice after PM~2.5~ treatment. The MMP-9 activity **(B)** increased in the lungs of WT and ACE2 KO mice at 2 days postinstillation but only remained at higher level in those of ACE2 KO mice at 5 days postinstillation. All values are expressed as the mean ± SD from each group; \* *p* \< 0.05 and \*\* *p* \< 0.01 compared with the sham value in the same group; † *p* \< 0.05 compared with 5 days to 2 days postinstillation in same group; \# *p* \< 0.05 and \#\# *p* \< 0.01 compared with the ACE2 KO mice to WT mice in the same day.](ijbsv14p0253g010){#F10}

![**Elevation of p-ERK1/2 and p-STAT3 levels after PM~2.5~ treatment.** WT and ACE2 KO mice treated PM~2.5~ or saline by intratracheal administration for consecutive 3 days and sacrificed at 2 and 5 days postinstillation. The expression of p-ERK1/2 and p-STAT3 in the lungs was determined by western blot **(A)**. ERK1/2 and STAT3 were used as the internal controls for p-ERK1/2 and p-STAT3, respectively. The expression of p-ERK1/2 and p-STAT3 in the non-PM~2.5~ treatment mice were calculated in 100% as the sham. The relative pulmonary p-ERK1/2 **(B)** and p-STAT3 **(C)** expression increased in both WT and ACE2 KO mice at 2 days postinstillation, but p-ERK1/2 **(B)** and p-STAT3 **(C)** only returned to normal level in WT mice at 5 days postinstillation. All values are expressed as the mean ± SD from each group; \* *p* \< 0.05 and \*\* *p* \< 0.01 compared with the Sham value in the same group; † *p* \< 0.05 and †† *p* \< 0.01 compared with the 5 days to 2 days postinstillation in same group.](ijbsv14p0253g011){#F11}
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